
Arthrosamid as a Bridge Option: Improving Quality of Life and Delaying Surgery for Moderate Knee Osteoarthritis
Arthrosamid is a minimally invasive polyacrylamide hydrogel injection offering pain relief and improved mobility for moderate knee osteoarthritis patients. Serving as a non-surgical bridge, it helps delay the need for knee replacement by cushioning damaged cartilage, enhancing joint lubrication, and supporting daily activities. Led by experts like Professor Paul Lee at the London Cartilage Clinic, Arthrosamid is tailored to individual needs, enabling patients to stay active, work, and enjoy hobbies longer. Unlike hyaluronic acid injections, Arthrosamid shows promising outcomes in symptom management and quality of life improvement. While not a cure, it provides a safe, effective treatment option to manage symptoms and postpone surgery under specialist care.




